a case using extracorporeal ionizing radiation to sterilize the tumorous calvaria intraoperatively, followed by reimplantation of the treated bone flap. 17 In this paper we report the long-term follow-up of that case, as well as results of using extracorporeal irradiation of tumorous calvaria (EITC) for an additional 20 patients treated similarly.
Methods
After study approval by the Virginia Commonwealth University institutional review board, a retrospective chart review was performed. Clinical and demographic information was collected, as well as data from the following variables: rates of calvarial tumor recurrence, cosmetic results as determined by clinical examination, and bone resorption via imaging. The decision to perform EITC was typically anticipated preoperatively, but determined intraoperatively, if upon inspection the bone flap was invaded by tumor (Fig. 1) . The bone flap was covered in wet gauze, wrapped to maintain sterility, and then delivered to the Radiation Oncology department. The bone flap was then inserted into the tray accessory mount on the clinical linear accelerator. One centimeter of bolus was placed above and below the bone flap and treatment was delivered with 6-MV photons to a total dose of 120 Gy prescribed to D max (the maximum point dose). Treatment time was 7 minutes, with the total process taking approximately 15 minutes. After the intracranial tumor resection was completed, the irradiated craniotomy bone flap was reimplanted and the wound was closed in a standard fashion.
results
Since the originally reported patient (Case 1), 20 additional patients have received EITC (Table 1 Figs. 1 and 2 ). As noted in Fig. 2 , cranial flaps were sometimes less calcified than adjacent cranial bone by virtue of the prior presence of tumor involvement with reduction of bone calcium. One patient required reoperation for cranial hardware removal that was not related to EITC. This patient underwent postoperative local external beam radiation therapy for her dural lymphoma and subsequently suffered scalp atrophy, resulting in unacceptable protrusion of the cranial plating hardware. Eighteen (86%) of 21 patients were diagnosed with meningioma: 12 (67%) with WHO Grade I, 5 (28%) with WHO Grade II, and 1 (6%) with WHO Grade III. The remaining 3 patients presented with dural-based B-cell lymphoma with extensive adjacent bone invasion (n = 2) and metastatic adenocarcinoma of the lung (n = 1).
Discussion
We have performed EITC in 21 patients with a mean follow-up period of 41 months. Our results indicate no calvarial tumor recurrence, bone resorption requiring revision, or infection. The EITC procedure is feasible and can be performed in less than 20 minutes. Calvarial reconstruction in neurooncological surgery is an important component in structural and cosmetic outcome. However, managing tumor invasion of the calvaria can be challenging, especially when it involves the craniofacial or skull base region. Different options have been described, including artificial prostheses, autologous and allogeneic bone graft, and autoclaving the autologous bone graft. 5, 8, 23, [29] [30] [31] Numerous publications have confirmed that autologous bone grafting is considered the standard means of cranial reconstruction and is associated with lower complication rates and better outcomes. 4, 9, 12, 13, 18, 22, 27, 28, 34 The advantages of autologous grafting include the avoidance of foreign material implantation, which may lead to inflammatory response, donor graft rejection, and higher infection rates. 1, 35 Furthermore, because the patient's own calvaria is used, it may lead to better structural and cosmetic outcome, reduced operative time, and lowered cost. 5, 12, [29] [30] [31] 33 Autologous bone grafting options include heterotopic autologous bone graft and sterilized autologous bone graft. Heterotopic autologous bone graft requires harvesting of local unaffected calvaria, which may lead to donor site morbidity and increased operative time. [29] [30] [31] 33 The sterilized autologous bone graft technique destroys invaded tumorous cells and allows for reimplantation of the patient's calvaria flap. [29] [30] [31] 33 Traditionally, this has been accomplished by autoclaving the tumorous calvarial flap and was first described by Naffziger in 1936. 19 Subsequent follow-up studies of this technique indicated no recurrence of tumor in the treated calvaria, but partial resorption was observed radiologically in 19% of the cases. [29] [30] [31] 33 Autoclaving has been shown to reduce torsional strength of up to 23% in mammalian diaphyseal bone.
14 The structural degradation associated with autoclaving may compromise the structural integrity of the reimplanted autoclaved calvarial flap, although this has not been directly studied. An alternative sterilization technique to autoclaving is the use of ionizing radiation. This technique has been described in the maxillofacial and orthopedic literature for malignant musculoskeletal tumors, where the involved tumorous bone is resected, irradiated extracorporeally, and reimplanted. 3, 6, 10, 11, 15, 21, 25, 32 Recently, long-term studies (mean follow-up range of 45-66 months) indicated no local tumor recurrence at the extracorporeally irradiated skeletal bone. 2, 3, 6, 21 Both animal and in vitro human studies directly comparing autoclaving with irradiation indicated a superior biomechanical profile and better incorporation of the reimplanted bone with irradiation. 6, 7, 24 When cadaveric bone flaps are used for implantation, they are irradiated to extremely high doses in the range of 1000-40,000 Gy to destroy antigens as well as infectious agents. 20 However, this can also denature structural proteins, which can impair mechanical integrity and promote demineralization or resorption of the treated calvaria. 20 In the setting of autologous bone flaps, a smaller dose of radiation, between 50 and 200 Gy, can provide complete tumor sterilization without the structural degradation caused by high-dose irradiation or autoclaving. Similar low doses between 50 and 300 Gy are also administered in orthopedic cases as described above. Animal studies utilizing intraoperative extracorporeal irradiation with lower doses have demonstrated excellent incorporation of the bone graft without structural integrity compromise. 7, 26, 32 Extracorporeal irradiation to sterilize tumorous autologous bone graft has been successfully used in malignant musculoskeletal tumors. However, to our knowledge, there is only 1 report utilizing this technique in neurooncological pathologies, 16 aside from our original prior case report. 17 The study by Lauritzen et al. performed EITC in 4 patients with meningioma with a limited 1-year follow-up. 16 All patients tolerated the procedure well with no recurrence, but 1 patient did require revision of the bone flap due to resorption. The current study is a larger case series of 21 patients with a longer mean follow-up period of 41 months, with no complications or calvarial tumor recurrences. The main limitation of this study is the length of the follow-up period. The majority of the cases (57%) were WHO Grade I meningiomas, which have an inherently low recurrence rate. Furthermore, calvarial resorption may take multiple years to become apparent. Therefore, a longer follow-up period may be necessary to determine the long-term outcome of EITC. Future studies investigating EITC in more aggressive pathologies and with longer follow-up periods are recommended.
conclusions
Calvaria reconstruction following craniectomy for tumorous bone represents an important component in structural and cosmetic outcome. Our long-term experience with EITC has been excellent with no local tumor recurrence or complications. We believe that it represents an excellent and efficient option for cranial reconstruction in such patients.
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